Bye-law 12, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD6-ZZ1]

As at 7 September 2026. In force from 15 October 2022.

In National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [R1M-SGR]. This text from 15 October 2022. No other text held.

Synthetic. This instrument, its title, its number and the words of this section are generated by the register.

Cite: Bye-law 12, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD6-ZZ1]. Machine: SD6-ZZ1.

Opportunity of hearing.—No order under these bye-laws refusing an application, or otherwise to the prejudice of any importer of drugs, shall be made unless he has been given a notice in writing of not less than fifteen days to show cause against the proposed order, has been given a copy of every document on which the order is proposed to be founded, and has been heard if he so desires; and the Drugs Controller shall communicate the order made to him in Form 19 within twenty-one days of the order.

Defined terms in this text (0)

none

Made under this bye-law, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this bye-law (0)

none